首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital
【24h】

Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital

机译:突尼斯医院生产肠杆菌酶肠杆菌菌的发生与表征

获取原文
获取原文并翻译 | 示例
           

摘要

Carbapenem-resistant Enterobacteriaceae have become of particular concern, since they were quickly disseminated in various areas in the world. The aim of the study was to investigate the prevalence of carbapenemase production among clinical isolates of Enterobacteriaceae recovered from the Military Hospital of Tunisia. Bacterial isolates (n=125) were recovered from patients in diverse services from March 2014 to February 2016 and identified by Vitek II Compact((R)). The multiplex PCR for bla(VIM), bla(IMP), bla(NDM), bla(KPC), and bla(OXA-48) with subsequent amplicon detection by reverse hybridization was performed with the Hyplex SuperBug ID test system (AmplexDiagnostics GmbH, Gars-Bahnhof, Germany). The 125 strains showed resistance to carbapenems of which 102 strains (81.6%) were carbapenemase-producing Enterobacteriaceae and were identified as Klebsiella pneumoniae (85.2%), Enterobacter cloacae (9.8%), Escherichia coli (2.9%), Providencia stuartii (0.9%) and Enterobacter aerogenes (0.9%). These strains were isolated mainly from blood, anal, and urine samples. Patients were mainly hospitalized in the intensive care units, surgery, and medical services. All strains were resistant to ertapenem (100%) and 55.8% showed resistance to imipenem. Carbapenemases genes detected in our study were as follows: bla(OXA-48) (84 isolates), bla(NDM-1) (8 isolates), bla(OXA-48) + bla(VIM) (5 isolates), and bla(OXA-48) + bla(NDM-1) (5 isolates). Our research provides epidemiological data showing the quick spread of carbapenem-resistant bacteria in our region, which calls for new surveillance strategies and strict hygiene rules.
机译:耐肠道肠杆菌植被已成为特别关注,因为它们在世界各个地区迅速传播。该研究的目的是探讨从突尼斯军队医院恢复的肠杆菌痤疮的临床分离株中碳碱酶产生的患病率。从2014年3月到2016年2月,从多元化服务中的患者中回收了细菌分离株(n = 125),并由Vitek II紧凑型((r))确定。通过HyPlex Superbug ID测试系统进行通过反向杂交进行随后的扩增子检测的BLA(Vim),BLA(IMP),BLA(NDM),BLA(KPC)和BLA(OXA-48)的多重PCR(kPc)和BLA(OXA-48)(AmplexDiagnostics GmbH ,Gars-Bahnhof,德国)。 125株表现出对碳癌蛋白酶的耐药症耐药性(81.6%)的耐药酶产生的肠杆菌,并被鉴定为Klebsiella肺炎(85.2%),肠杆菌(9.8%),普罗西州大肠杆菌(2.9%),Providencia stuartii(0.9% )肠杆菌空气(0.9%)。这些菌株主要来自血液,肛门和尿液样本。患者主要在重症监护病房,手术和医疗服务中住院。所有菌株均为抗开腹(100%)和55.8%的抗胰腺炎。在我们的研究中检测到的碳甲脲酶基因如下:BLA(OXA-48)(84个分离物),BLA(NDM-1)(8分离物),BLA(OXA-48)+ BLA(Vim)(5分离株)和BLA (OXA-48)+ BLA(NDM-1)(5分离株)。我们的研究提供了流行病学数据,显示了我们地区的耐鲤鱼抗菌的快速传播,呼吁新的监测策略和严格的卫生规则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号